What is the equity of IRIDEX this year?
IRIDEX has equity of 9.52 M USD this year.
IRIDEX Equity 2024
IRIDEX Equity
9.52 M USD
Ticker
IRIX
ISIN
US4626841013
WKN
912341
In 2024, IRIDEX's equity was 9.52 M USD, a -44.74% increase from the 17.23 M USD equity in the previous year.
IRIDEX Aktienanalyse
What does IRIDEX do?
IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing IRIDEX's Equity
IRIDEX's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IRIDEX's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating IRIDEX's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
IRIDEX's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in IRIDEX’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about IRIDEX stock
What was the equity of IRIDEX compared to the previous year?
The equity of IRIDEX has increased/decreased by -44.74% decreased compared to the previous year.
What impact does a high equity have on investors of IRIDEX?
A high equity is advantageous for investors of IRIDEX as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of IRIDEX?
A low equity can be a risk for investors of IRIDEX, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of IRIDEX affect the company?
An increase in equity of IRIDEX can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of IRIDEX affect the company?
A reduction in equity of IRIDEX can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of IRIDEX?
Some factors that can affect the equity of IRIDEX include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of IRIDEX so important for investors?
The equity of IRIDEX is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can IRIDEX take to change the equity?
To change equity, IRIDEX can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does IRIDEX pay?
Over the past 12 months, IRIDEX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IRIDEX is expected to pay a dividend of 0 USD.
What is the dividend yield of IRIDEX?
The current dividend yield of IRIDEX is .
When does IRIDEX pay dividends?
IRIDEX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IRIDEX?
IRIDEX paid dividends every year for the past 0 years.
What is the dividend of IRIDEX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IRIDEX located?
IRIDEX is assigned to the 'Health' sector.
Wann musste ich die Aktien von IRIDEX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IRIDEX from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did IRIDEX pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of IRIDEX in the year 2023?
In the year 2023, IRIDEX distributed 0 USD as dividends.
In which currency does IRIDEX pay out the dividend?
The dividends of IRIDEX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von IRIDEX
Our stock analysis for IRIDEX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IRIDEX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
